A detailed history of Ameritas Investment Partners, Inc. transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 9,419 shares of APLT stock, worth $77,895. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,419
Holding current value
$77,895
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$4.04 - $6.37 $38,052 - $59,999
9,419 New
9,419 $43,000
Q2 2022

Aug 12, 2022

SELL
$0.76 - $2.64 $896 - $3,112
-1,179 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$29.41 - $51.23 $18,528 - $32,274
630 Added 114.75%
1,179 $43,000
Q4 2019

Feb 13, 2020

BUY
$10.16 - $28.14 $3,850 - $10,665
379 Added 222.94%
549 $15,000
Q3 2019

Nov 14, 2019

BUY
$8.08 - $10.99 $1,373 - $1,868
170 New
170 $2,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $397M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.